Urinary biomarkers of oxidative status.
暂无分享,去创建一个
Ivan Spasojevic | Peter M. Scarbrough | I. Spasojević | Dora Il'yasova | Peter Scarbrough | D. Il’yasova
[1] L. Wagenknecht,et al. Urinary F2‐Isoprostanes, Obesity, and Weight Gain in the IRAS Cohort , 2012, Obesity.
[2] H. Sampath,et al. Regulation of DNA glycosylases and their role in limiting disease , 2012, Free radical research.
[3] F. Clavel-Chapelon,et al. The Associations of Advanced Glycation End Products and Its Soluble Receptor with Pancreatic Cancer Risk: A Case–Control Study within the Prospective EPIC Cohort , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[4] Steffen Loft,et al. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids , 2012, Free radical research.
[5] L. Wagenknecht,et al. Urinary F2-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes , 2011, Diabetes Care.
[6] Dean P. Jones,et al. Biomarkers of Oxidative Stress Study IV: ozone exposure of rats and its effect on antioxidants in plasma and bronchoalveolar lavage fluid. , 2011, Free radical biology & medicine.
[7] M. Lagarde,et al. Functional lipidomics of oxidized products from polyunsaturated fatty acids. , 2011, Chemistry and Physics of Lipids.
[8] A. Soro-Paavonen,et al. RAGE biology, atherosclerosis and diabetes. , 2011, Clinical science.
[9] N. Rothman,et al. Obesity, age, and oxidative stress in middle-aged and older women. , 2011, Antioxidants & redox signaling.
[10] André M Deelder,et al. Mild and selective labeling of malondialdehyde with 2-aminoacridone: assessment of urinary malondialdehyde levels. , 2011, The Analyst.
[11] A. Sigurdson,et al. Variation in base excision repair capacity. , 2011, Mutation research.
[12] R. Silber,et al. Prognostic Potential and Tumor Growth-Inhibiting Effect of Plasma Advanced Glycation End Products in Non-Small Cell Lung Carcinoma , 2011, Molecular medicine.
[13] W. Atkins,et al. Interactions of glutathione transferases with 4-hydroxynonenal , 2011, Drug metabolism reviews.
[14] L. Jones,et al. Effects of aerobic training on oxidative status in postsurgical non-small cell lung cancer patients: a pilot study. , 2011, Lung cancer.
[15] S. Cummings,et al. F2‐Isoprostanes and Adiposity in Older Adults , 2011, Obesity.
[16] G. Münch,et al. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease , 2011, Clinical chemistry and laboratory medicine.
[17] Michael J Morgan,et al. Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.
[18] H. Forman. Reactive oxygen species and α,β‐unsaturated aldehydes as second messengers in signal transduction , 2010, Annals of the New York Academy of Sciences.
[19] D. Millington,et al. Allantoin in human urine quantified by ultra-performance liquid chromatography-tandem mass spectrometry. , 2010, Analytical biochemistry.
[20] B. Halliwell,et al. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. , 2010, Antioxidants & redox signaling.
[21] P. Marcom,et al. Urinary Biomarkers of Oxidative Status in a Clinical Model of Oxidative Assault , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[22] D. Millington,et al. Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. , 2010, Analytical biochemistry.
[23] X. Shu,et al. Intra-Person Variation of Urinary Biomarkers of Oxidative Stress and Inflammation , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[24] Jianling Xie,et al. Trends in advanced glycation end products research in diabetes mellitus and its complications , 2010, Molecular and Cellular Biochemistry.
[25] Trevor A. Mori,et al. Measurement of urinary F2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances , 2010, Free radical research.
[26] J. Marks,et al. Individual responses to chemotherapy-induced oxidative stress , 2010, Breast Cancer Research and Treatment.
[27] L. Jones,et al. Quantification of Selected F2Isoprostanes and Creatinine in Human Urine by Liquid Chromatographyelectrospray Tandem Mass Spectrometry (LCESIMS/MS) , 2010 .
[28] Heather C. Kuiper,et al. Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation study. , 2010, Free radical biology & medicine.
[29] D. Pelclova,et al. Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[30] P. Marcom,et al. Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[31] H. Yamato,et al. Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG. , 2009, Free radical biology & medicine.
[32] M. Cooke. A commentary on "Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG". What is ELISA detecting? , 2009, Free radical biology & medicine.
[33] B. Henderson,et al. Association of Plasma Micronutrient Levels and Urinary Isoprostane with Risk of Lung Cancer: The Multiethnic Cohort Study , 2009, Cancer Epidemiology Biomarkers & Prevention.
[34] B. Halliwell,et al. Allantoin in human plasma, serum, and nasal-lining fluids as a biomarker of oxidative stress: avoiding artifacts and establishing real in vivo concentrations. , 2009, Antioxidants & redox signaling.
[35] N. Rothman,et al. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] B. Henderson,et al. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F2t in serum or urine with prostate cancer risk: the multiethnic cohort , 2009, Cancer Causes & Control.
[37] N. Brown,et al. Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[38] E. Lakatta,et al. RAGE signaling in inflammation and arterial aging. , 2009, Frontiers in bioscience.
[39] J. Nourooz-Zadeh. Key issues in F2-isoprostane analysis. , 2008, Biochemical Society transactions.
[40] S. Basu. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. , 2008, Antioxidants & redox signaling.
[41] Steffen Loft,et al. Measurement and Meaning of Oxidatively Modified DNA Lesions in Urine , 2008, Cancer Epidemiology Biomarkers & Prevention.
[42] P. Vineis,et al. Validation of biomarkers for the study of environmental carcinogens: a review , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[43] C. Harris,et al. Inflammation and cancer: An ancient link with novel potentials , 2007, International journal of cancer.
[44] G. Vita,et al. RAGE‐NF‐κB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy , 2007 .
[45] F. Guéraud,et al. 4-Hydroxynonenal in foodstuffs: heme concentration, fatty acid composition and freeze-drying are determining factors , 2007, Redox report : communications in free radical research.
[46] S. Garcia,et al. Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. , 2007, Journal of pharmaceutical and biomedical analysis.
[47] A. Berrebi,et al. Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals. , 2007, DNA repair.
[48] I. M. Jones,et al. Exploration of methods to identify polymorphisms associated with variation in DNA repair capacity phenotypes. , 2006, Mutation research.
[49] C. Giulivi,et al. Current analytical methods for the detection of dityrosine, a biomarker of oxidative stress, in biological samples. , 2007, Mass spectrometry reviews.
[50] G. Vita,et al. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. , 2007, Acta neurologica Scandinavica.
[51] K. Roszkowski,et al. Severe oxidatively damaged DNA after cisplatin treatment of cancer patients , 2006, International journal of cancer.
[52] M. Desai,et al. Polymorphisms in Nucleotide Excision Repair Genes and DNA Repair Capacity Phenotype in Sisters Discordant for Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[53] J. Morrow,et al. Intraindividual Variability of Plasma Antioxidants, Markers of Oxidative Stress, C-Reactive Protein, Cotinine, and Other Biomarkers , 2006, Epidemiology.
[54] Steffen Loft,et al. Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer. , 2006, Carcinogenesis.
[55] A. Pilger,et al. 8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures , 2006, International archives of occupational and environmental health.
[56] V. Mužáková,et al. Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[57] J. Bonventre,et al. Release of Free F2-isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases* , 2006, Journal of Biological Chemistry.
[58] C. Cunningham,et al. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. , 2006, Analytical biochemistry.
[59] H. Tsukahara,et al. Evaluation of a urinary multi-parameter biomarker set for oxidative stress in children, adolescents and young adults , 2006, Free radical research.
[60] R. Sinha,et al. Urinary Malondialdehyde-Equivalents during ingestion of meat cooked at high or low temperatures , 1995, Lipids.
[61] L. Mcgirr,et al. Urinary malondialdehyde as an indicator of lipid peroxidation in the diet and in the tissues , 1984, Lipids.
[62] J. Wal,et al. Enzyme immunoassay for a urinary metabolite of 4-hydroxynonenal as a marker of lipid peroxidation. , 2006, Free radical biology & medicine.
[63] C. Chow,et al. An improved method for the measurement of malondialdehyde in biological samples , 2006, Lipids.
[64] J. Kornhuber,et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome , 2005, Journal of Neural Transmission.
[65] G. Zalba,et al. NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. , 2005, Antioxidants & redox signaling.
[66] M. Evans,et al. DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. , 2005, Mutation research.
[67] B. Tomlinson,et al. A study of the effect of oral glucose loading on plasma oxidant:antioxidant balance in normal subjects , 2005, European journal of nutrition.
[68] D. H. Thiel,et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? , 2005, Free radical biology & medicine.
[69] B. Ames,et al. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. , 2005, Free radical biology & medicine.
[70] A. Kong,et al. Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.
[71] V. Lee,et al. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. , 2005, The Journal of rheumatology.
[72] F. Violante,et al. A method for routine quantitation of urinary 8-hydroxy-2'-deoxyguanosine based on solid-phase extraction and micro-high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.
[73] J. Cravedi,et al. Dihydroxynonene mercapturic acid, a urinary metabolite of 4‐hydroxynonenal, as a biomarker of lipid peroxidation , 2005, BioFactors.
[74] N. Vermeulen,et al. Evaluation of a Multi-parameter Biomarker Set for Oxidative Damage in Man: Increased Urinary Excretion of Lipid, Protein and DNA Oxidation Products after One Hour of Exercise , 2004, Free radical research.
[75] J. Morrow,et al. Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. , 2004, Annals of epidemiology.
[76] Yuan-TehLee,et al. Ascorbate Supplement Reduces Oxidative Stress in Dyslipidemic Patients Undergoing Apheresis , 2004 .
[77] B. Halliwell,et al. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? , 2004, British journal of pharmacology.
[78] T. Ohishi,et al. The Maillard protein cross-link pentosidine in urine from diabetic patients , 1993, Diabetologia.
[79] H. Matsumaru,et al. Quantitative determination of urinary 8‐hydroxy‐2′‐deoxyguanosine level in healthy Japanese volunteers , 2004, BioFactors.
[80] K. Uchida,et al. Nϵ-(3-Methylpyridinium)lysine, a Major Antigenic Adduct Generated in Acrolein-modified Protein* , 2003, Journal of Biological Chemistry.
[81] C. Exley,et al. Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[82] D. Malencik,et al. Dityrosine as a product of oxidative stress and fluorescent probe , 2003, Amino Acids.
[83] B. Tudek,et al. Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. , 2003, Cancer research.
[84] R. Schaur,et al. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. , 2003, Molecular aspects of medicine.
[85] K. Uchida. Histidine and lysine as targets of oxidative modification , 2003, Amino Acids.
[86] K. Davies,et al. Tyrosine oxidation products: analysis and biological relevance , 2003, Amino Acids.
[87] H. Tsukahara,et al. Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis. , 2003, Life sciences.
[88] E. Benjamin,et al. Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[89] Takeo Kato,et al. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. , 2003, Endocrine journal.
[90] J. Morrow,et al. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[91] H. Rüdiger,et al. Urinary excretion of 8-hydroxy-2'-deoxyguanosine measured by high-performance liquid chromatography with electrochemical detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[92] T. Osawa,et al. Thiolation of Protein-bound Carcinogenic Aldehyde , 2002, The Journal of Biological Chemistry.
[93] H. Brismar,et al. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. , 2002, Kidney international.
[94] J. Heinecke. Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress. , 2002, Free radical biology & medicine.
[95] J Bangsbo,et al. Allantoin formation and urate and glutathione exchange in human muscle during submaximal exercise. , 2001, Free radical biology & medicine.
[96] R. Hotchkiss,et al. NADPH oxidase of neutrophils elevates o,o'-dityrosine cross-links in proteins and urine during inflammation. , 2001, Archives of biochemistry and biophysics.
[97] A. Schmidt,et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.
[98] Alexander Pilger,et al. Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults , 2001, Free radical research.
[99] K. Roszkowski,et al. 8-Oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine levels in human urine do not depend on diet , 2001, Free radical research.
[100] D. O'Connor,et al. Plasma Hydrogen Peroxide Production in Human Essential Hypertension: Role of Heredity, Gender, and Ethnicity , 2000, Hypertension.
[101] C. Leeuwenburgh,et al. Increased oxidative stress in kwashiorkor. , 2000, The Journal of pediatrics.
[102] M. Obrenovich,et al. Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. , 2000, Investigative ophthalmology & visual science.
[103] L. Marnett,et al. Xenobiotic-metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and the Mutagen, Malondialdehyde* , 2000, The Journal of Biological Chemistry.
[104] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[105] Dean P. Jones,et al. Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning? , 2000, Free radical biology & medicine.
[106] E. Anggard,et al. Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels. , 2000, Free radical biology & medicine.
[107] J. Morrow,et al. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. , 2000, Free radical biology & medicine.
[108] B. Halliwell,et al. Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet , 2000, Free radical research.
[109] Kayoko Kita,et al. Is allantoin in serum and urine a useful indicator of exercise-induced oxidative stress in humans? , 2000, Free radical research.
[110] J. Morrow. THE ISOPROSTANES: THEIR QUANTIFICATION AS AN INDEX OF OXIDANT STRESS STATUS IN VIVO† , 2000, Drug metabolism reviews.
[111] B. Gladen,et al. Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning? , 2000, Free radical biology & medicine.
[112] S. Métairon,et al. Urinary isoprostane excretion is not confounded by the lipid content of the diet , 1999, FEBS letters.
[113] J. Holloszy,et al. Hydroxyl radical generation during exercise increases mitochondrial protein oxidation and levels of urinary dityrosine. , 1999, Free radical biology & medicine.
[114] B. Tomlinson,et al. Simultaneous measurement of allantoin and urate in plasma: analytical evaluation and potential clinical application in oxidant:antioxidant balance studies. , 1999, Clinical chemistry.
[115] D. Wu,et al. Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column. , 1999, Journal of pharmaceutical and biomedical analysis.
[116] G. Gibson,et al. Protein‐Bound Acrolein , 1999, Journal of neurochemistry.
[117] J. Morrow,et al. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. , 1999, Methods in enzymology.
[118] R. Strange,et al. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. , 1999, IARC scientific publications.
[119] J. Cravedi,et al. Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. , 1998, Chemical research in toxicology.
[120] L. Roberts,et al. Measurement of lipid peroxidation. , 1998, Free radical research.
[121] E. Niki,et al. Protein-bound acrolein: potential markers for oxidative stress. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[122] J. Cravedi,et al. 1,4-Dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine. , 1998, Chemical research in toxicology.
[123] G. FitzGerald,et al. Nomenclature of isoprostanes: a proposal. , 1997, Prostaglandins.
[124] J. Witztum,et al. Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis , 1997, Hepatology.
[125] J. Morrow,et al. A nomenclature system for the isoprostanes. , 1997, Prostaglandins.
[126] J. Baynes,et al. New biomarkers of Maillard reaction damage to proteins. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[127] L. Sayre,et al. Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. , 1995, Chemical research in toxicology.
[128] J. Cravedi,et al. Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat. , 1995, Chemical research in toxicology.
[129] C. Cross,et al. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite , 1994, FEBS letters.
[130] K. Davies,et al. Dityrosine: a marker for oxidatively modified proteins and selective proteolysis. , 1994, Methods in enzymology.
[131] E. Stadtman,et al. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[132] Wei Li,et al. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. , 1993, The Journal of biological chemistry.
[133] H. Esterbauer,et al. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination. , 1992, The Biochemical journal.
[134] J. Baynes,et al. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. , 1991, The Journal of biological chemistry.
[135] J. Morrow,et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[136] D. Janero,et al. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. , 1990, Free radical biology & medicine.
[137] B. Halliwell,et al. Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. , 1990, Chemico-biological interactions.
[138] D. Muzny,et al. Urate oxidase: primary structure and evolutionary implications. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[139] J. Baynes,et al. The Amadori product on protein: structure and reactions. , 1989, Progress in clinical and biological research.
[140] S. Rajagopalan,et al. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. , 1988, Cancer research.
[141] A. Cerami,et al. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.
[142] L. Piché,et al. Identification of N-ɛ-(2-propenal)lysine as the main form of malondialdehyde in food digesta , 1988 .
[143] B. Halliwell,et al. Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo? , 1987, The Biochemical journal.
[144] M. Hecker,et al. Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: development of a novel enzyme assay. , 1987, Archives of biochemistry and biophysics.
[145] W. Pryor. Oxy-radicals and related species: their formation, lifetimes, and reactions. , 1986, Annual review of physiology.
[146] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[147] J. Zweier,et al. Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen. , 1985, The Journal of biological chemistry.
[148] B. Ames,et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[149] A. Cerami,et al. The biochemistry of the complications of diabetes mellitus. , 1981, Annual review of biochemistry.
[150] S. K. Wadman,et al. Nϵ-(carboxymethyd)lysine, a constituent of human urine , 1975 .
[151] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[152] E. Young,et al. ON THE ESTIMATION OF ALLANTOIN BY THE RIMINI-SCHRYVER REACTION , 1942 .